Fig. 1.
Number and proportion of resistant MTBC strains by years_
| 2015 | 2016 | 2017 | 2018 | 2019 | Total | ||
|---|---|---|---|---|---|---|---|
| Sensitive to all drugs | 11 | 42 | 49 | 61 | 19 | 182 | (78.1) |
| INH | 2 | 3 | 13 | 12 | 9 | 39 | (16.7) |
| SM | 2 | 1 | 11 | 12 | 8 | 34 | (14.6) |
| RIF | 1 | – | 2 | 2 | 2 | 7 | (3) |
| EMB | – | – | – | 1 | 1 | 2 | (0.8) |
| İNH + SM | 2 | 1 | 8 | 7 | 5 | 23 | (9.9) |
| INH + RIF + SM (MDR-TB) | 1 | 2 | 2 | 2 | 7 | (3) | |
Number, species, AFB positivity and distribution of Mycobacterial strains according to clinical samples_
| AFB | MTBC | NTMs | ||
|---|---|---|---|---|
| Respiratory | 198 | 98 | 159 | 39 |
| Sputum | 157 | 89 | 120 | 37 |
| Bronchoalveolar lavage | 37 | 7 | 35 | 2 |
| Tracheal aspirate | 4 | 2 | 4 | – |
| Tissue | 22 | 3 | 21 | 1 |
| Lymph Node Biopsy | 12 | 2 | 12 | – |
| Other Tissues | 10 | 1 | 9 | 1 |
| Sterile body fluid | 22 | – | 22 | – |
| Pleura | 13 | – | 13 | – |
| BOS | 6 | – | 6 | – |
| Peritoneum | 3 | – | 3 | – |
| Abscess | 18 | 3 | 17 | 1 |
| Fasting gastric fluid | 11 | – | 9 | 2 |
| Urine | 7 | – | 5 | 2 |
| Total | 278 | 104 | 233 | 45 |